Mohindru Mani
Transaction: 07/14/2026
BUY
Change
+34,364
Price
$1.33
Filing
07/16/2026
Type
BUY
Cardiff Oncology, Inc.
CRDF • Biotechnology
$1.09
▲ +0.01 (+0.93%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$74.55M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 3.67Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.09
Change0.93%
Shares Out68.40M
Market Cap$74.55M
Enterprise Value$40.49M
52W Range0.76 - 3.31
Beta1.44
P/E-1.86
P/S184.54
P/B2.81
P/FCF-1.82
EV/Sales100.22
Price$1.09
Change0.93%
Shares Out68.40M
Market Cap$74.55M
Enterprise Value$40.49M
52W Range0.76 - 3.31
Beta1.44
P/E-1.86
P/S184.54
P/B2.81
P/FCF-1.82
EV/Sales100.22
EV/EBITDA-1.00
EV/FCF-0.99
Earnings Yield-53.73%
FCF Yield-54.88%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-82.56%
Profit Margin-77.32%
Debt/Eq0.02
Current Ratio3.67
Quick Ratio3.67
Target$2.00
Target Upside83.49%
Target Median$2.00
Target Range2.00 - 2.00
Volume1.26M
Avg Volume1.29M
EPS Surprise-0.05
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 3.67Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 15 analyst votes · 2026-09-05
70/100
Bullish
Bullish
7
Hold
7
Bearish
1
Price Target
2026-08-13
Low
$2.00
Mean
$2.00
Median
$2.00
High
$2.00
Insider Transactions
Recent executive and insider activity
Mohindru Mani
Transaction: 07/14/2026
BUY
Change
+34,364
Price
$1.46
Filing
07/16/2026
Type
BUY
PACE GARY W
Transaction: 07/14/2026
BUY
Change
+687,285
Price
$1.33
Filing
07/16/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mohindru Mani | BUY | +34,364 | $1.33 | 07/14/2026 | 07/16/2026 |
| Mohindru Mani | BUY | +34,364 | $1.46 | 07/14/2026 | 07/16/2026 |
| PACE GARY W | BUY | +687,285 | $1.33 | 07/14/2026 | 07/16/2026 |
| PACE GARY W | BUY | +687,285 | $1.46 | 07/14/2026 | 07/16/2026 |
| PACE GARY W | BUY | +30,000 | $1.22 | 06/18/2026 | 06/22/2026 |
| Mohindru Mani | BUY | +24,703 | $1.21 | 06/18/2026 | 06/22/2026 |
| PACE GARY W | BUY | +40,565 | $1.59 | 06/11/2026 | 06/15/2026 |
| Markin Rodney S | BUY | +40,565 | $1.59 | 06/11/2026 | 06/15/2026 |
| TANNENBAUM RENEE P | BUY | +40,565 | $1.59 | 06/11/2026 | 06/15/2026 |
| White Lale | BUY | +40,565 | $1.59 | 06/11/2026 | 06/15/2026 |
| Armitage James O | BUY | +40,565 | $1.59 | 06/11/2026 | 06/15/2026 |
| Aggarwal Ajay | OTHER | 0 | Not reported | 04/27/2026 | 04/28/2026 |
| Aggarwal Ajay | BUY | +400,000 | $1.72 | 04/27/2026 | 04/28/2026 |
| Smeal Tod | BUY | +300,000 | $1.63 | 04/14/2026 | 04/16/2026 |
| Muntner Joshua B | BUY | +486,650 | $1.58 | 04/06/2026 | 04/16/2026 |
| Muntner Joshua B | OTHER | 0 | Not reported | 04/06/2026 | 04/16/2026 |
| Mohindru Mani | BUY | +600,000 | $1.62 | 03/31/2026 | 04/02/2026 |
| Mohindru Mani | BUY | +200,000 | $1.56 | 02/17/2026 | 02/18/2026 |
| Lindsay Brigitte Ute | BUY | +200,000 | $1.60 | 02/13/2026 | 02/18/2026 |
| Lindsay Brigitte Ute | OTHER | +166,320 | $3.58 | 01/27/2026 | 02/09/2026 |